U.S. Capital Markets Stock News

DTE Energy (DTE) is back in focus after reporting second quarter 2026 earnings per share of $1.32 that exceeded estimates, alongside large grid and clean energy investments and new gas plant plans. DTE Energy’s recent earnings beat and large grid, clean energy and gas plant commitments come as the share price sits at $135.86, with a year to date share price return of 4.22% and a 3 year total shareholder return of 47.34% that signals momentum built over a longer horizon, even as the 30 day...

In August 2026, HP Inc. reported fiscal third-quarter revenue of US$15.68 billion, with net income of US$661 million, raised its full-year 2026 GAAP diluted EPS guidance to US$2.52–US$2.62, issued fourth-quarter EPS guidance of US$0.74–US$0.84, and completed a multi-year buyback program totaling US$19.91 billion for about 764.78 million shares. At the same time, HP highlighted a mix shift toward higher-priced premium and AI-focused PCs and filed a US$2.36 billion ESOP-related common stock...

With Fed Chair Kevin Warsh signaling a tougher line on inflation and hinting at higher interest rates, investors are watching how this new rate story ripples through banks and insurers. Some stocks from our U.S. Interest-Rate Beneficiary Financials screener could see their business models tested or supported by this shift, and others may lag. This article unpacks three of them and explains why their exposure to the latest Fed stance matters to your portfolio decisions. The three stocks...

With central banks signalling that interest rates could stay higher for longer as they focus on persistent inflation, investors face more pressure on richly priced stocks. Cash flow and valuation matter more when borrowing costs are not cheap. That is where the Undervalued Stocks Based On Cash Flows screener can help. This article highlights three stocks that combine cash flow characteristics with prices below estimated fair value. The three stocks in this article are just a starting sample,...

BioArctic and Eli Lilly (NYSE: LLY) announced a research collaboration to develop a new Alzheimer's treatment that combines BioArctic's BrainTransporter technology with an Eli Lilly drug candidate. The agreement focuses on improving delivery of Alzheimer’s therapies to the brain and expands Eli Lilly's neurology partnership efforts. The collaboration adds another project to Eli Lilly's neurodegenerative disease pipeline, an area that remains a key focus for large pharmaceutical...

Earlier this week, analysts reaffirmed a bullish stance on Twilio, with an average brokerage recommendation around Strong Buy and a Zacks Rank #1 reflecting strong agreement on its earnings prospects. The recent upward revisions to Twilio’s earnings estimates highlight rising analyst confidence in the company’s ability to convert its engagement platform into stronger profitability. Next, we’ll explore how this increased analyst optimism on Twilio’s earnings outlook shapes and potentially...

Earlier this month, Micron Technology expanded its leadership ranks, created a US$10.00 billion Micron Research Labs network, and opened a 60,000-square-foot Boise Training Center to deepen U.S. memory R&D and workforce development for advanced AI-era manufacturing. Together, the leadership changes, long-horizon research commitment, and hands-on training hub tighten Micron’s alignment between technology roadmaps, operations, and talent pipelines for AI-focused memory demand. We’ll now...

Qiagen (NYSE:QGEN) has commercially launched QIAsymphony Connect, an automated clinical nucleic acid extraction platform listed with the FDA and EUDAMED. The system is designed to support streamlined, standardized workflows for molecular diagnostics labs across a wide range of testing applications. Qiagen highlighted initial market adoption, with early clinical customers already integrating QIAsymphony Connect into routine operations. The platform targets key growth areas such as liquid...

Earlier in August 2026, Amylyx Pharmaceuticals completed a US$500.20 million follow-on common stock offering after reporting that its Phase 3 LUCIDITY trial of avexitide for post-bariatric hypoglycemia met all primary and secondary endpoints with a strong safety profile. The results highlight avexitide as a potential first-in-class GLP-1 receptor antagonist for a condition with no FDA-approved therapies, and Amylyx now plans to file a New Drug Application with the FDA by the end of...

Global rate expectations have shifted again as the US 10 year Treasury yield responds to fresh inflation warnings. Higher and stickier borrowing costs can pressure heavily indebted companies. It can also highlight fast growing stocks where insiders already have significant skin in the game. This article walks through three stocks from our Fast Growing Stocks With High Insider Ownership screener that fit that profile right now. The three stocks below are just a sample from this theme, while...

In August 2026, Anschutz Entertainment Group Inc. and Archer Aviation Inc. announced a collaboration to build downtown Los Angeles’ first vertiport at L.A. LIVE, making Archer the exclusive air taxi partner for the district and advancing infrastructure plans for its Midnight aircraft network. This agreement not only extends Archer’s planned Los Angeles network ahead of the LA28 Games but also anchors its urban air mobility vision around a high-profile entertainment hub with integrated...

NextEra Energy stock has delivered a 33.8% gain over the past three years, yet current checks suggest the shares now sit close to an intrinsic value estimate while traditional market multiples still screen them as relatively inexpensive. That split leaves investors weighing recent performance against what the valuation tools are currently signalling. The 33.8% return over three years points to solid shareholder gains that may already reflect a meaningful portion of NextEra Energy's quality...

Eaton stock has delivered strong gains over the past five years, yet current valuation checks send mixed signals, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples suggest the shares may still be reasonable on relative terms. For investors, the split between these views raises the question of how much of Eaton’s recent strength is already reflected in the price. Eaton has returned about 161.6% over five years, which puts extra focus on...

Rising 10 year US Treasury yields are pushing up funding costs across markets, which makes every dollar of financial strength matter more for smaller companies. That is where the Financially Fit Penny Stocks screener comes in. It filters for low priced stocks with healthier balance sheets and cash profiles than many early stage peers. This article highlights three stocks from the screener that show how that opportunity looks in practice. The three Financially Fit Penny Stocks highlighted...

Clear Secure (YOU) has drawn attention after recent share price swings, with the stock down about 26% over the past month and roughly 22% over the past 3 months despite reported annual revenue and net income growth. At the current share price of $43.43, Clear Secure’s recent 30 day share price decline of about 26% and 90 day share price decline of about 22% sit in contrast to a year to date share price return of 26% and a 3 year total shareholder return of 121%. Together, these figures...

In recent days, Silicon Motion Technology’s shares moved above their 20-day moving average while analysts raised earnings estimates without any downward revisions, reflecting improving sentiment toward the company’s near-term performance. This combination of a bullish technical signal and concentrated upward estimate revisions suggests analysts see the company’s current fundamentals as stronger than previously thought. We’ll now examine how this wave of upward earnings estimate revisions may...

Quanta Services’ tokenized stock on Robinhood reached a new all‑time high on 27 August 2026, spotlighting heightened interest in the company’s economic exposure product that mirrors price performance and corporate actions without conferring voting rights. This milestone underscores how investor attention is increasingly focusing on Quanta’s role in long-term grid replacement, transmission expansion, and renewable interconnection projects. Next, we’ll examine how heightened interest around...

Bristol-Myers Squibb (NYSE:BMY) presented new long term and real world data for Camzyos in obstructive hypertrophic cardiomyopathy at the European Society of Cardiology Congress. Five year results from the EXPLORER-LTE cohort highlighted sustained efficacy for oHCM patients with consistent improvements in functional capacity and symptoms. Real world evidence across global populations reported no new safety concerns and aligned with outcomes seen in clinical trials. The data set reinforces...

Earlier this week, commentary on Churchill Downs highlighted that despite solid operations across horse racing, online wagering, and gaming, the company is growing more slowly and generating weaker returns on capital than peers, raising questions about its growth runway. The most striking takeaway is that, even with healthy cash flow and profitable core assets, investors are increasingly focused on management’s difficulty in finding new high-return growth opportunities. Next, we’ll examine...

Modine Manufacturing stock has had a very strong five year run, yet current checks such as an intrinsic value estimate and market multiples still point to the shares trading below what the underlying cash flows may justify. With that backdrop, investors are weighing how much of Modine Manufacturing's past gains are already reflected in the current US$177.63 share price. Over the past five years, Modine Manufacturing has returned about 13x. This makes the current valuation especially...

Global Ship Lease stock has posted very strong multi year returns, yet the current valuation checks suggest the shares may still be pricing in a discount relative to its fundamentals. After this kind of run, investors are asking whether the stock is already reflecting the good news or if there is still room based on the broad valuation signals. Over the past 3 years, Global Ship Lease has returned about 186.0%, which puts extra focus on whether the current price still reflects a margin of...

Chipotle Mexican Grill stock has gained 11.1% over the past month, yet on several valuation checks it currently screens as expensive rather than a clear bargain. Both the intrinsic value estimate using a Discounted Cash Flow (DCF) approach and market based multiples point to the shares trading at a premium to those models. The 11.1% move over the past month highlights renewed optimism around Chipotle Mexican Grill, which raises the bar for what future cash flows need to justify. Expectations...

Morgan Stanley stock has surged over the past three years, yet the current valuation checks suggest the shares now trade close to what many models assess as a fair intrinsic value rather than an obvious bargain. The Excess Returns intrinsic value estimate points to pricing that is slightly above fair value, while earnings based multiples also suggest the stock is broadly in line with peers. Over the past 3 years, Morgan Stanley has delivered a total return of about 174.6%, which puts extra...

Moderna (NasdaqGS:MRNA) received FDA approval for its updated 2026-2027 COVID-19 vaccines Spikevax and mNEXSPIKE targeting new SARS-CoV-2 variants. The decision covers the upcoming 2026-2027 vaccination season and keeps Moderna active in the evolving COVID-19 vaccine market. The updated formulations extend the company’s infectious disease franchise beyond oncology focused programs covered in recent updates. Zooming out from Moderna’s latest COVID-19 vaccine approval, this kind of recurring...